Levonorgestrel-releasing intrauterine device for dysfunctional uterine bleeding
Record ID 32007000383
English
Authors' objectives:
The levonorgestrel-releasing intrauterine device (LNG-IUD), which provides local administration of the hormone into the uterine cavity, is being used as a treatment for dysfunctional uterine bleeding (DUB), also known as idiopathic menorrhagia, in premenopausal women with no underlying pelvic condition that requires another type of therapy or surgery. The goal of this therapy is to reduce excessive menstrual blood loss and related symptoms and improve quality of life. The LNG-IUD, which is approved as a reversible contraceptive, is intended as a minimally invasive alternative to the more definitive treatments, endometrial ablation and hysterectomy.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2006
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Levonorgestrel
- Metrorrhagia
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.